Outlook Therapeutics, Inc. — Form D

Outlook Therapeutics, Inc. of ISELIN, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2025-01-27. The offering totals $32.0M. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (45)

Showing 25 of 45 people.

NameRoleLocation
Gerd G AuffarthDirectorIselin, NJ
Julian G GangolliDirectorIselin, NJ
Yezan H HaddadinDirectorIselin, NJ
Julia A HallerDirectorIselin, NJ
Kurt J HilzingerDirectorIselin, NJ
Andong G HuangDirectorIselin, NJ
Lawrence A KenyonDirectorIselin, NJ
Faisal G SukhtianDirectorIselin, NJ
Randy H ThurmanDirectorIselin, NJ
Jeff A EvansonExecutive OfficerIselin, NJ
Lawrence A KenyonExecutive OfficerIselin, NJ
Pankaj MohanDirectorPrinceton, NJ
Pankaj MohanExecutive OfficerPrinceton, NJ
Julian GangolliRelated PersonIselin, NJ
Jeff Russell EvansonExecutive OfficerIselin, NJ
C. Russell TrenaryDirectorIselin, NJ
C. Russell TrenaryExecutive OfficerIselin, NJ
Todd BradyDirectorAtlanta, GA
Randy ThurmanDirectorMonmouth Junction, NJ
Yezan HaddadinDirectorIselin, NJ
Yezan HaddadinRelated PersonIselin, NJ
Jeff G EvansonExecutive OfficerMonmouth Junction, NJ
Terry G DagnonExecutive OfficerMonmouth Junction, NJ
Donald GriffithDirectorPrinceton, NJ
Donald GriffithExecutive OfficerPrinceton, NJ

Other filings by this issuer (12)

FiledFormOfferingSold
2026-05-07D$5.0M
2024-04-16D$13.3M$5.0M
2024-03-29D$159.0M$60.0M
2023-01-06D$1.0M$1.0M
2023-01-06D$31.8M$31.8M
2021-02-12D$4.0M$4.0M
2020-06-09D$16.0M$16.0M
2020-03-11D$8.0M$8.0M
2017-09-25D$40.1M$3.3M
2015-12-23D$50.0M$6.3M
2015-10-13D$14.5M$14.5M
2015-08-10D$31.1M$31.1M

More